Add to ORKGIn patients with a low clinical probability of pulmonary embolism who also have negative D-dimer test results, withholding additional diagnostic testing does not increase the frequency of venous thromboembolism during follow-up. Low clinical probability and negative D-dimer test results occur in 50% of outpatients and in 20% of inpatients who have suspected pulmonary embolism
BACKGROUND: The safety of a D-dimer (DD) measurement in cancer patients with clinically suspected pu...
Risk assessment for pulmonary embolism (PE) currently relies on physician judgment, clinical decisio...
Background: Pulmonary embolism (PE) is a frequent and potentially severe disease. So objective testi...
International audienceBACKGROUND: D-dimer tests are used in various diagnostic strategies to exclude...
The unresolved issue of false-positive D-dimer results in the diagnostic workup of pulmonary embolis...
D-dimer is a multifaceted biomarker of concomitant activation of coagulation and fibrinolysis, which...
D-dimer is a multifaceted biomarker of concomitant activation of coagulation and fibrinolysis, which...
BACKGROUND: D-dimer levels remain elevated in many patients after completion of a 6-month anticoagul...
D-dimer is a multifaceted biomarker of concomitant activation of coagulation and fibrinolysis, which...
Objective. To determine the utility of high quantitative D-dimer levels in the diagnosis of pulmonar...
BACKGROUND: We evaluated whether a highly sensitive D-dimer test is clinically useful and safe for r...
BackgroundAn unlikely' clinical decision rule with a negative D-dimer result safely excludes pulmona...
Background Pulmonary embolism (PE) can occur when a thrombus (blood clot) travels through the veins ...
International audiencePrevious studies have suggested the utility of D-Dimer ELISA assays in elimina...
International audienceClinical outcome studies have shown that it is safe to withhold anticoagulant ...
BACKGROUND: The safety of a D-dimer (DD) measurement in cancer patients with clinically suspected pu...
Risk assessment for pulmonary embolism (PE) currently relies on physician judgment, clinical decisio...
Background: Pulmonary embolism (PE) is a frequent and potentially severe disease. So objective testi...
International audienceBACKGROUND: D-dimer tests are used in various diagnostic strategies to exclude...
The unresolved issue of false-positive D-dimer results in the diagnostic workup of pulmonary embolis...
D-dimer is a multifaceted biomarker of concomitant activation of coagulation and fibrinolysis, which...
D-dimer is a multifaceted biomarker of concomitant activation of coagulation and fibrinolysis, which...
BACKGROUND: D-dimer levels remain elevated in many patients after completion of a 6-month anticoagul...
D-dimer is a multifaceted biomarker of concomitant activation of coagulation and fibrinolysis, which...
Objective. To determine the utility of high quantitative D-dimer levels in the diagnosis of pulmonar...
BACKGROUND: We evaluated whether a highly sensitive D-dimer test is clinically useful and safe for r...
BackgroundAn unlikely' clinical decision rule with a negative D-dimer result safely excludes pulmona...
Background Pulmonary embolism (PE) can occur when a thrombus (blood clot) travels through the veins ...
International audiencePrevious studies have suggested the utility of D-Dimer ELISA assays in elimina...
International audienceClinical outcome studies have shown that it is safe to withhold anticoagulant ...
BACKGROUND: The safety of a D-dimer (DD) measurement in cancer patients with clinically suspected pu...
Risk assessment for pulmonary embolism (PE) currently relies on physician judgment, clinical decisio...
Background: Pulmonary embolism (PE) is a frequent and potentially severe disease. So objective testi...